Get the Stockscreener App
5.15
2.79%
0.14
After Hours:
5.15
Serina Therapeutics Inc stock is traded at $5.15, with a volume of 19,811.
It is up +2.79% in the last 24 hours and down -0.77% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$5.01
Open:
$5.02
24h Volume:
19,811
Relative Volume:
0.21
Market Cap:
$52.79M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.63%
1M Performance:
-0.77%
6M Performance:
-3.16%
1Y Performance:
-23.82%
1-Day Range:
$4.8801
$5.15
1-Week Range:
$4.8801
$5.83
52-Week Range:
$3.81
$8.14
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
5.15 | 52.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
Will Serina Therapeutics Inc. stock maintain growth storyEarnings Recap Report & Weekly High Conviction Ideas - newser.com
Backtesting results for Serina Therapeutics Inc. trading strategiesShort Setup & Real-Time Market Trend Scan - newser.com
Serina Therapeutics CSO Randall Moreadith sells $22495 in stock By Investing.com - Investing.com Canada
Using R and stats models for Serina Therapeutics Inc. forecastingEarnings Summary Report & Risk Managed Investment Signals - newser.com
Serina Therapeutics CSO Randall Moreadith sells $22495 in stock - Investing.com
How dovish Fed policy supports Serina Therapeutics Inc. (2BO) stockJuly 2025 Volume & Community Consensus Picks - newser.com
How Serina Therapeutics Inc. (2BO) stock performs in easing cyclesDividend Hike & AI Forecast for Swing Trade Picks - newser.com
What earnings revisions data tells us about Serina Therapeutics Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Is Serina Therapeutics Inc. stock supported by free cash flowJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Serina Therapeutics Inc. stock daily chart insightsJuly 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Using fundamentals and technicals on Serina Therapeutics Inc.Analyst Upgrade & Advanced Swing Trade Entry Plans - newser.com
What does recent volatility data suggest for Serina Therapeutics Inc.July 2025 Movers & Daily Volume Surge Signals - newser.com
Applying Wyckoff theory to Serina Therapeutics Inc. stockQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Technical analysis overview for Serina Therapeutics Inc. stockJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Serina Therapeutics Launches Enhanced Corporate - GlobeNewswire
Phase 1b n=88 — Serina Therapeutics launches enhanced communications platform to support SER-252 trial - Stock Titan
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease - Sahm
Serina Therapeutics says submits IND to FDA, receives HREC approval in Australia for SER-252SEC filing - MarketScreener
Serina Therapeutics Draws First $5 Million Funding Tranche - GlobeNewswire
$5M tranche: Serina advances SER-252—IND filed, HREC approval; global registrational trial to start Q4 2025 - Stock Titan
Is Serina Therapeutics Inc. stock overpriced at current multiplesChart Signals & Stock Timing and Entry Methods - newser.com
Serina Therapeutics Secures $5M for Parkinson’s Trial - MSN
Strategies to average down on Serina Therapeutics Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-09-29 10:57:18 - newser.com
Published on: 2025-09-29 06:57:35 - newser.com
Serina Therapeutics Inc Stock (SER) Financials Data
There is no financial data for Serina Therapeutics Inc (SER). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Cap:
|
Volume (24h):